Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 20, 2014
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytori Therapeutics, Inc.
| 2.87K |
—
|
—
| +27.18% | 13.42K |
May 19
| |||||||
Cytori Therapeutics, Inc.
| 10.55K |
—
|
—
|
∞
| 10.55K |
Jan 1
| |||||||
Cytori Therapeutics, Inc.
| 6.1K |
—
|
—
|
∞
| 6.1K |
Jan 1
| |||||||
Cytori Therapeutics, Inc.
| 10K |
—
|
—
|
∞
| 10K |
Jan 1
| |||||||
Cytori Therapeutics, Inc.
| 3K |
$3.15 | $9,450.00 | +12.29% | 27.4K |
Aug 19
| |||||||
Cytori Therapeutics, Inc.
| 6K |
—
|
—
| +32.61% | 24.4K |
Jan 1
| |||||||
Cytori Therapeutics, Inc.
| 768 |
—
|
—
| +4.36% | 18.4K |
Feb 9
| |||||||
Cytori Therapeutics, Inc.
| 768 |
—
|
—
| +4.36% | 18.4K |
Feb 9
| |||||||
Cytori Therapeutics, Inc.
|
0
|
$6.18 | -$115,356.50 |
—
| 2.47K |
Jan 20
|
Scheduled
| ||||||
Cytori Therapeutics, Inc.
| 2.47K |
—
|
—
|
∞
| 2.47K |
Apr 30
| |||||||
Cytori Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 29
| |||||||
Cytori Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Cytori Therapeutics, Inc.
| 2K |
$5.55 | $11,105.60 | +15.20% | 15.16K |
Nov 28
| |||||||
Cytori Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 26
| |||||||
Cytori Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 6
| |||||||
MacRopore Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
MacRopore Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
MacRopore Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
MacRopore Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||